ReviewCurrent neuropharmacology2025

Disease-Modifying Symptomatic Treatment (DMST): The Potential Role of Vortioxetine in the Treatment of Depression in Patients with Multiple Sclerosis.

Ettore Dolcetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.